Back to search
FDAFDA · Food and drugs·Recall number D-1815-2015

1% Lidocaine HCl Injection, USP, 10 mg/mL, 30 mL Vial, Single-dose Preservative Free, Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-4279-02

Published September 30, 2015 · Recall initiated: August 25, 2015

Summary

FDA records drug Class II recall D-1815-2015, published September 30, 2015 and initiated August 25, 2015. Recalling firm: Hospira, Inc.; Status: Ongoing; Reported quantity: 100,200 Vials; Lot: Lot #: 44-359-DK, Exp 08/01/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.

What to do

Voluntary: Firm initiated · Letter

Get an email if LIDOCAINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LIDOCAINE HYDROCHLORIDE
Manufacturer
Hospira, Inc.
Distributor
Nationwide
Lot
Lot #: 44-359-DK, Exp 08/01/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 1% Lidocaine HCl Injection, USP, 10 mg/mL, 30 mL Vial, Single-dose Preservative Free, Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-4279-02 recalled?

Yes. FDA published recall D-1815-2015 on September 30, 2015. Reported hazard: Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LIDOCAINE HYDROCHLORIDE.